Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5460438

EMD:Ref Document

Bid Value: Ref Document

437 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5457173

EMD:Ref Document

Bid Value: Ref Document

437 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5450913

EMD:Ref Document

Bid Value: Ref Document

437 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Fampridine N3

Deadline: 10 Nov 2025

Germany

Ref. No.: 5393652

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Testosterone Gel

Deadline: 10 Nov 2025

Germany

Ref. No.: 5386779

EMD:Ref Document

Bid Value: Ref Document

21 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5310892

EMD:Ref Document

Bid Value: Ref Document

193 Days Left

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

Deadline: 05 Apr 2026

Germany

Ref. No.: 5306291

EMD:Ref Document

Bid Value: Ref Document

167 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5266211

EMD:Ref Document

Bid Value: Ref Document

437 Days Left

Medicines With The Active Ingredient Fampridine Atc N07Xx07

Deadline: 31 Mar 2026

Germany

Ref. No.: 5229599

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Medicines With The Active Ingredient Tiotropium Bromide Atc R03Bb04 Except In The Dosage Form Hard Capsules With Powder For Inhalation

Deadline: 31 Mar 2026

Germany

Ref. No.: 5227518

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Medicines With The Active Ingredient Dupilumab Atc D11Ah05

Deadline: 31 Mar 2026

Germany

Ref. No.: 5227070

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Medicines With The Active Ingredient Combination Formoterol Glycopyrronium Bromide And Beclometasone Atc R03Al09

Deadline: 31 Mar 2026

Germany

Ref. No.: 5226698

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08

Deadline: 31 Mar 2026

Germany

Ref. No.: 5226107

EMD:Ref Document

Bid Value: Ref Document

162 Days Left

Open House Drug Discount Agreements Calcipotriol And Betamethasone Excluding Ointments Atc D05Ax22

Deadline: 05 Apr 2026

Germany

Ref. No.: 5166613

EMD:Ref Document

Bid Value: Ref Document

167 Days Left

Open House Drug Discount Agreements Lamivudine Tenofovir Disoproxil And Doravirine Atc J05Ar24

Deadline: 05 Apr 2026

Germany

Ref. No.: 5162939

EMD:Ref Document

Bid Value: Ref Document

167 Days Left

Discover Tenders by Hygienic Or Pharmaceutical Articles Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Hygienic Or Pharmaceutical Articles Sector

Filter Your Search

FREE Trial plan for all new users!